These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 8523406)

  • 1. Phenethylthiazolethiourea (PETT) compounds, a new class of HIV-1 reverse transcriptase inhibitors. 1. Synthesis and basic structure-activity relationship studies of PETT analogs.
    Bell FW; Cantrell AS; Högberg M; Jaskunas SR; Johansson NG; Jordan CL; Kinnick MD; Lind P; Morin JM; Noréen R
    J Med Chem; 1995 Dec; 38(25):4929-36. PubMed ID: 8523406
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The PETT series, a new class of potent nonnucleoside inhibitors of human immunodeficiency virus type 1 reverse transcriptase.
    Ahgren C; Backro K; Bell FW; Cantrell AS; Clemens M; Colacino JM; Deeter JB; Engelhardt JA; Hogberg M; Jaskunas SR
    Antimicrob Agents Chemother; 1995 Jun; 39(6):1329-35. PubMed ID: 7574525
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phenethylthiazolylthiourea (PETT) compounds as a new class of HIV-1 reverse transcriptase inhibitors. 2. Synthesis and further structure-activity relationship studies of PETT analogs.
    Cantrell AS; Engelhardt P; Högberg M; Jaskunas SR; Johansson NG; Jordan CL; Kangasmetsä J; Kinnick MD; Lind P; Morin JM; Muesing MA; Noreén R; Oberg B; Pranc P; Sahlberg C; Ternansky RJ; Vasileff RT; Vrang L; West SJ; Zhang H
    J Med Chem; 1996 Oct; 39(21):4261-74. PubMed ID: 8863804
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structure-based design of N-[2-(1-piperidinylethyl)]-N'-[2-(5-bromopyridyl)]-thiourea and N-[2-(1-piperazinylethyl)]-N'-[2-(5-bromopyridyl)]-thiourea as potent non-nucleoside inhibitors of HIV-1 reverse transcriptase.
    Mao C; Vig R; Venkatachalam TK; Sudbeck EA; Uckun FM
    Bioorg Med Chem Lett; 1998 Aug; 8(16):2213-8. PubMed ID: 9873515
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bioisosteric modification of PETT-HIV-1 RT-inhibitors: synthesis and biological evaluation.
    Högberg M; Engelhardt P; Vrang L; Zhang H
    Bioorg Med Chem Lett; 2000 Feb; 10(3):265-8. PubMed ID: 10698450
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis and anti-HIV activities of urea-PETT analogs belonging to a new class of potent non-nucleoside HIV-1 reverse transcriptase inhibitors.
    Sahlberg C; Noréen R; Engelhardt P; Högberg M; Kangasmetsä J; Vrang L; Zhang H
    Bioorg Med Chem Lett; 1998 Jun; 8(12):1511-6. PubMed ID: 9873380
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structure-based design of non-nucleoside reverse transcriptase inhibitors of drug-resistant human immunodeficiency virus.
    Mao C; Sudbeck EA; Venkatachalam TK; Uckun FM
    Antivir Chem Chemother; 1999 Sep; 10(5):233-40. PubMed ID: 10574178
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anti-HIV activity of aromatic and heterocyclic thiazolyl thiourea compounds.
    Venkatachalam TK; Sudbeck EA; Mao C; Uckun FM
    Bioorg Med Chem Lett; 2001 Feb; 11(4):523-8. PubMed ID: 11229762
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phenylethylthiazolylthiourea (PETT) non-nucleoside inhibitors of HIV-1 and HIV-2 reverse transcriptases. Structural and biochemical analyses.
    Ren J; Diprose J; Warren J; Esnouf RM; Bird LE; Ikemizu S; Slater M; Milton J; Balzarini J; Stuart DI; Stammers DK
    J Biol Chem; 2000 Feb; 275(8):5633-9. PubMed ID: 10681546
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Design, synthesis, SAR, and molecular modeling studies of acylthiocarbamates: a novel series of potent non-nucleoside HIV-1 reverse transcriptase inhibitors structurally related to phenethylthiazolylthiourea derivatives.
    Ranise A; Spallarossa A; Schenone S; Bruno O; Bondavalli F; Vargiu L; Marceddu T; Mura M; La Colla P; Pani A
    J Med Chem; 2003 Feb; 46(5):768-81. PubMed ID: 12593657
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structural requirements for potent anti-human immunodeficiency virus (HIV) and sperm-immobilizing activities of cyclohexenyl thiourea and urea non-nucleoside inhibitors of HIV-1 reverse transcriptase.
    D'Cruz OJ; Venkatachalam TK; Mao C; Qazi S; Uckun FM
    Biol Reprod; 2002 Dec; 67(6):1959-74. PubMed ID: 12444075
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Piperidinylethyl, phenoxyethyl and fluoroethyl bromopyridyl thiourea compounds with potent anti-HIV activity.
    Venkatachalam TK; Sudbec EA; Mao C; Uckun FM
    Antivir Chem Chemother; 2000 Sep; 11(5):329-36. PubMed ID: 11142631
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stereochemistry of halopyridyl and thiazolyl thiourea compounds is a major determinant of their potency as nonnucleoside inhibitors of HIV-1 reverse transcriptase.
    Venkatachalam TK; Sudbeck EA; Mao C; Uckun FM
    Bioorg Med Chem Lett; 2000 Sep; 10(18):2071-4. PubMed ID: 10999473
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structure--activity relationship studies of 1-(4-chloro-2,5-dimethoxyphenyl)-3-(3-propoxypropyl)thiourea, a non-nucleoside reverse transcriptase inhibitor of human immunodeficiency virus type-1.
    Weitman M; Lerman K; Nudelman A; Major DT; Hizi A; Herschhorn A
    Eur J Med Chem; 2011 Feb; 46(2):447-67. PubMed ID: 21159409
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of stereochemistry on the anti-HIV activity of chiral thiourea compounds.
    Venkatachalam TK; Mao C; Uckun FM
    Bioorg Med Chem; 2004 Aug; 12(15):4275-84. PubMed ID: 15246104
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel derivatives of phenethyl-5-bromopyridylthiourea and dihydroalkoxybenzyloxopyrimidine are dual-function spermicides with potent anti-human immunodeficiency virus activity.
    D'Cruz OJ; Uckun FM
    Biol Reprod; 1999 Jun; 60(6):1419-28. PubMed ID: 10330101
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Urea-PETT compounds as a new class of HIV-1 reverse transcriptase inhibitors. 3. Synthesis and further structure-activity relationship studies of PETT analogues.
    Högberg M; Sahlberg C; Engelhardt P; Noréen R; Kangasmetsä J; Johansson NG; Oberg B; Vrang L; Zhang H; Sahlberg BL; Unge T; Lövgren S; Fridborg K; Bäckbro K
    J Med Chem; 1999 Oct; 42(20):4150-60. PubMed ID: 10514285
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structure-based design, parallel synthesis, structure-activity relationship, and molecular modeling studies of thiocarbamates, new potent non-nucleoside HIV-1 reverse transcriptase inhibitor isosteres of phenethylthiazolylthiourea derivatives.
    Ranise A; Spallarossa A; Cesarini S; Bondavalli F; Schenone S; Bruno O; Menozzi G; Fossa P; Mosti L; La Colla M; Sanna G; Murreddu M; Collu G; Busonera B; Marongiu ME; Pani A; La Colla P; Loddo R
    J Med Chem; 2005 Jun; 48(11):3858-73. PubMed ID: 15916438
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 2-(Aryl)-3-furan-2-ylmethyl-thiazolidin-4-ones as selective HIV-RT inhibitors.
    Rawal RK; Prabhakar YS; Katti SB; De Clercq E
    Bioorg Med Chem; 2005 Dec; 13(24):6771-6. PubMed ID: 16198576
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Selective non-nucleoside HIV-1 reverse transcriptase inhibitors. New 2,3-dihydrothiazolo[2,3-a]isoindol-5(9bH)-ones and related compounds with anti-HIV-1 activity.
    Mertens A; Zilch H; König B; Schäfer W; Poll T; Kampe W; Seidel H; Leser U; Leinert H
    J Med Chem; 1993 Aug; 36(17):2526-35. PubMed ID: 7689109
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.